Requirement of major histocompatibility complex-compatible microenvironment for spleen colony formation (CFU-S on day 12 but not on day 8)

Stem Cells

Volumn 15, Issue 6, 1997, Pages 461-468

  Sugiura, Kikuya ^a   Inaba, Muneo ^a   Hisha, Hiroko ^a   Borisov, Konstantin ^b   Sardiña, Evelio E ^b   Good, Robert A ^b   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Major histocompatibility complex; Restriction; Spleen colony formation

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; COLONY FORMING UNIT S; CONTROLLED STUDY; GENE LOCUS; HEMATOPOIETIC STEM CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; RECIPIENT; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

ANIMALIA;

EID: 0030728979     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150461     Document Type: Article

References (51)

1. Koenigsmann M, Griffin JD, DiCarlo J et al. Myeloid and erythroid progenitor cells from normal bone marrow adhere to collagen type I. Blood 1991;79:657-665.
2. Simmons PJ, Masinovsky B, Longecker BM et al. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992;80:388-395.
3. Yanai N, Sekine C, Yagita H et al. Role of integrin very late activation antigen-4 in stroma-dependent erythropoiesis. Blood 1994;83:2844-2850.
4. Funk PE, Stephan RP, Witte PL. Vascular cell adhesion molecule 1-positive reticular cells express interleukin-7 and stem cell factor in the bone marrow. Blood 1995;86:2661-2671.
5. Tsa S, Emerson SG, Shieff CA et al. Isolation of a human stromal cell strain secreting hemopoietic growth factors. J Cell Physiol 1986;127:137-145.
6. Kawashima I, Takiguchi Y. Interleukin-11: a novel stroma-derived cytokine. Prog Growth Factor Res 1992;4:191-206.
7. Nishikawa M, Ozawa K, Tojo A et al. Changes in hematopoiesis-supporting ability of C3H10T1/2 mouse embryo fibroblasts during differentiation. Blood 1993;81:1184-1192.
8. Itoh K, Friel J, Kluge N et al. A novel hematopoietic multilineage clone, Myl-D-7, is stromal cell-dependent and supported by an alternative mechanism(s) independent of stem cell factor/c-kit interaction. Blood 1996;87:3218-3228.
9. Knospe WH, Gregory SA, Husseini SG et al. Origin and recovery of colony-forming units in locally curetted bone marrow of mice. Blood 1972;39:331-340.
10. Fan H, Yasumizu R, Sugiura K et al. Histogenesis of hematopoietic bone marrow in adult mice. Exp Hematol 1990;18:159-166.
11. Friedenstein AJ, Ivanov-Smolenski AA, Chajlakjan RK et al. Origin of bone marrow stromal mechanocytes in radiochimeras and heterotopic transplants. Exp Hematol 1978;6:440-444.
12. Ishida T, Inaba M, Hisha H et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/Mp-lpr/lpr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1994;152:3119-3127.
13. Hisha H, Nishino T, Kawamura M et al. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination. Exp Hematol 1995;23:347-352.
14. Hashimoto F, Sugiura K, Inoue K et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 1997;89:49-54.
15. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal bone marrow cells. Radiat Res 1961;14:213-222.
16. Tsuchiyama J, Mori M, Okada S. Murine spleen stromal cell line SPY3-2 maintains long-term hematopoiesis in vitro. Blood 1995;85:3107-3116.
17. 0 phase. Biochem Biophys Res Commun 1987;147:687-694.
18. Sugiura K, Inaba M, Ogata H et al. Wheat germ agglutinin-positive cells in stem cell-enriched fraction of mouse bone marrow have potent natural suppressor activity. Proc Natl Acad Sci USA 1988;85:4824-4826.
19. Sugiura K, Yasumizu R, Iwai H et al. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival. Thymus 1991;18:137-153.
20. + T cells as negative regulators. Exp Hematol 1994;22:947-953.
21. Lapidot T, Terenzi A, Singer TS et al. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood 1989;73:2025-2032.
22. Magli MC, Iscove NN, Odarcheno N. The transient nature of early hematopoietic spleen colony forming units. Nature 1982;295:527-529.
23. Cudkowicz G, Stimpfling JH. Deficient growth of C57BL marrow cells transplanted in F1 hybrid mice. Association with the histocompatibility-2 locus. Immunology 1964;7:291-306.
24. Sentman CL, Kumar V, Koo G et al. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule and ability of mice to reject bone marrow allografts. J Immunol 1989;142:1847-1853.
25. Sharabi Y, Aksentijevich I, Sundt TM III et al. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990;172:195-202.
26. Wolf NS, Priestley GV. Kinetics of early and late spleen colony development. Exp Hematol 1986;14:676-682.
27. Lengerová A, Matousek V, Zelenÿ V. Analysis of deficient colony-forming performance of bone marrow cells in non-syngenic cell milieu. The impact of non-immune interactions on the behaviour of pluripotent stem cells and the role of H-2 gene products. Transplant Rev 1973;15:89-122.
28. Murphy MJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med 1987;165:1212-1217.
29. Murphy MJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Difference in kinetics and target antigens recognized. J Exp Med 1987;166:1499-1509.
30. Shimamura K, Kaminsky SG, Nakamura I. Acute rejection of allogeneic hematopoietic progenitors by genetically resistant mice. Eur J Immunol 1989;19:1165-1170.
31. + cells into cytotoxic T cells during acute rejection of allogeneic bone marrow grafts. Immunogenetics 1990;31:161-168.
32. Ferrara JLM, Mauch P, Dijken PJV et al. Evidence that antiasialo GM1 in vivo improved engrafrment of T cell-depleted bone marrow in hybrid recipients. Transplantation 1990;49:134-138.
33. Cudkowicz G, Nakamura I. Genetics of the murine hematopoietic-histocompatibility system. An overview. Transplant Proc 1983;15:2058-2063.
34. Rembecki RM, Kumar V, David CS et al. Polymorphism of Hh-1, the mouse hematopoietic histocompatibility locus. Immunogenetics 1988;28:158-170.
35. El Badri NS, Good RA. Lymphohematopoietic reconstitution using wheat germ agglutinin-positive hematopoietic stem cell transplantation within but not across the major histocompatibility antigen barriers. Proc Natl Acad Sci USA 1993;90:6681-6685.
36. van den Berg H, van Tol MJD, Waaijer JLM et al. Study of possible correlations between in vitro growth of bone marrow stromal and hematopoietic precursor cells early after allogeneic bone marrow transplantation. Exp Hematol 1992;20:184-191.
37. Dexter TM, Moore MAS, Sheridan APC. Maintenance of hematopoietic stem cells and production of differentiated progeny in allogeneic and semiallogeneic bone marrow chimeras in vitro. J Exp Med 1977;145:1612-1616.
38. Stagsted J, Reaven GM, Hansen T et al. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. Cell 1990;62:297-307.
39. Hsu D, Olefsky JM. Effect of a major histocompatibility complex class I peptide on insulin-like growth factor-I receptor internalization and biological signaling. Endocrinology 1993;133:1247-1251.
40. Stagsted J, Olsson L, Holman GD et al. Inhibition of internalization of glucose transporters and IGF-II receptors. Mechanism of action of MHC class I-derived peptides which augment the insulin response in rat adipose cells. J Biol Chem 1993;268:22809-22813.
41. Aron DC. Insulin-like growth factor I and erymropoiesis. Biofactors 1992;3:211-216.
42. Tsarfaty G, Longo DL, Murphy WJ. Human insulin-like growth factor I exerts hematopoietic growth-promoting effects after in vivo administration. Exp Hematol 1994;22:1273-1277.
43. Jardieu P, Clark R, Mortensen D et al. In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J Immunol 1994;152:4320-4327.
44. Shimon I, Shpilberg O. The insulin-like growth factor system in regulation of normal and malignant hematopoiesis. Leuk Res 1995;19:233-240.
45. Arkins S, Rebeiz N, Brunke-Reese DL et al. The colony-stimulating factors induce expression of insulin-like growth factor-I messenger ribonucleic acid during hematopoiesis. Endocrinology 1995;136:1153-1160.
46. Ratajczak MZ, Kuczynski WI, Onodera K et al. A reappraisal of the role of insulin-like growth factor I in the regulation of human hematopoiesis. J Clin Invest 1994;94:320-327.
47. Van Zant G, Scott-Micus K, Tompson BP et al. Stem cell quiescence/activation is reversible by serial transplantation and is dependent of stromal cell genotype in mouse aggregation chimeras. Exp Hematol 1992;20:470-475.
48. Geppert TD, Wacholtz MC, Davis LS et al. Activation of human T cells by cross-linking class I MHC molecules. J Immunol 1988;140:2155-2164.
49. Gur H, El-Zaatari F, Geppert TD et al. Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transduction. J Exp Med 1990;172:1267-1270.
50. Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the a3 domain of class I MHC. Science 1991;252:1424-1427.
51. Ogata H, Bradley WG, Inaba M et al. Long-term repopulation of hematolymphoid cells with only a few hemopoietic stem cells in mice. Proc Natl Acad Sci USA 1995;92:5945-5949.